glp 1 b12 longevity microdose Microdosing Noom introduces longevity-focused GLP-1 microdosing

The trial found that participants with obesity alone who got MariTide lost up to 20% of their body weight, on average, after 52 weeks, compared with just 2.6% in the placebo group

But because obesity drives many of the major diseases of aging, including heart disease, cancer, dementia, arthritis and diabetes, the US Centers for Medicare and Medicaid Services says it makes sense to pilot a test to see whether the medications might ultimately save the program money and improve health outcomes

Novo Nordisk reports that production has stabilized, allowing the company to meet current and future demand in the U.S

Starting GLP-1 injections can feel intimidating, but knowing where to inject and how to make it easy is key to staying consistent

After ingesting, avoid eating, drinking, or taking any other oral medications for at least 30 minutes so your body can fully absorb the medicine